Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients

Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients

Abstract Background Patient selection for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is critically important to optimizing outcomes. There is currently no literature regarding the safety of CRS/HIPEC in patients with cirrhosis. The aim of this case series is to...

Full description

Bibliographic Details
Main Authors: Anna Weiss, Erin P. Ward, Joel M. Baumgartner, Andrew M. Lowy, Kaitlyn J. Kelly
Format: Article
Language:English
Published: BMC 2018-04-01
Series:World Journal of Surgical Oncology
Subjects:
Cytoreductive surgery
Cytoreduction
HIPEC
Cirrhosis
Online Access:http://link.springer.com/article/10.1186/s12957-018-1389-3

Internet

http://link.springer.com/article/10.1186/s12957-018-1389-3

Similar Items